TrialPloS one2012

Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study.

Rolf Jorde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.